Investors sold shares of Humana Inc. (NYSE:HUM) on strength during trading on Friday. $31.37 million flowed into the stock on the tick-up and $84.13 million flowed out of the stock on the tick-down, for a money net flow of $52.76 million out of the stock. Of all equities tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $0.03 for the day and closed at $256.56

HUM has been the subject of several research reports. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Thursday, June 1st. Argus upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Friday, June 9th. BidaskClub upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Citigroup Inc. initiated coverage on shares of Humana in a research report on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price for the company. Finally, Bank of America Corporation upped their target price on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $244.35.

The company has a market capitalization of $37.08 billion, a P/E ratio of 21.11 and a beta of 0.87. The stock has a 50-day moving average price of $247.64 and a 200-day moving average price of $229.85.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the company earned $2.30 EPS. On average, analysts anticipate that Humana Inc. will post $11.55 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Tuesday, August 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. Humana’s dividend payout ratio is presently 13.06%.

In other Humana news, VP Timothy S. Huval sold 7,803 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $258.14, for a total value of $2,014,266.42. Following the completion of the sale, the vice president now directly owns 8,831 shares of the company’s stock, valued at approximately $2,279,634.34. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the completion of the sale, the insider now directly owns 18,042 shares of the company’s stock, valued at $4,672,878. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 60,566 shares of company stock valued at $15,326,746. 0.80% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its position in Humana by 2,281.7% in the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares during the period. Vanguard Group Inc. boosted its position in Humana by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock valued at $2,380,366,000 after buying an additional 157,868 shares during the period. FMR LLC boosted its position in Humana by 29.3% in the 2nd quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock valued at $1,571,264,000 after buying an additional 1,479,210 shares during the period. State Street Corp boosted its position in Humana by 1.4% in the 1st quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock valued at $1,293,487,000 after buying an additional 84,716 shares during the period. Finally, Capital Research Global Investors boosted its position in Humana by 9.7% in the 2nd quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock valued at $940,182,000 after buying an additional 346,069 shares during the period. 95.14% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/10/traders-sell-humana-inc-hum-on-strength-hum.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.